Stem Cell Transplant in Juvenile Scleroderma - Patient Forum 2024

Explore the potential of Autologous Stem Cell Transplantation (ASCT) as a treatment for juvenile scleroderma in this informative 37-minute video presentation. Dr. Kathryn Torok, Director of the Pediatric Scleroderma Clinic at Pittsburgh Children's Hospital, delves into the protocols and outcomes observed at the Pittsburgh Scleroderma Center. Gain valuable insights into this cutting-edge treatment approach, originally presented on June 3, 2024, as part of the 3rd annual SRF Patient Forum, "Collaborating for a Cure." Discover the latest advancements in juvenile scleroderma treatment and understand how stem cell transplantation may offer new hope for patients and their families.